High performance liquid fingerprint spectrum of Tibetan medicine gnaphalium affine and method for determining contents of six components

The HPLC method was used to establish the high-performance liquid fingerprint map and component content determination method of koji koji koji koji koji and tinderma. The problem of identifying koji koji koji and tinderma was solved, and the effective evaluation and control of the quality of koji koji were achieved, and the accuracy of identifying medicinal materials was improved. Sex and comprehensiveness.

CN118897033APending Publication Date: 2024-11-05CHONGQING ACAD OF CHINESE MATERIA MEDICA
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411119337.4
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-15
Publication Date
2024-11-05

AI Technical Summary

Technical Problem

The existing technology cannot effectively solve the problem of quality control and identification of Tibetan medicine koji koji, especially when confused with tindergrass, and lacks efficient fingerprint maps and component content measurement methods, which makes it difficult to evaluate and guarantee the quality of medicinal materials.

Method used

The HPLC method was used to establish the high-performance liquid fingerprint of koji koji, and the content of 6 major chemical components was determined by measuring the contents of chlorogenic acid, caffeic acid, isochlorogenic acid A, quercetin, luteolin and apigenin. Establish a feature map to distinguish between koji koji and tindergrass, and improve the accuracy and comprehensiveness of the identification of medicinal materials.

Benefits of technology

The obvious distinction between koji koji and tindergrass has been achieved, the quality control methods of Tibetan medicine koji koji are enriched and improved, and the accuracy of medicinal materials identification and scientific quality evaluation have been improved.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118897033A_ABST
    Figure CN118897033A_ABST
Patent Text Reader

Abstract

The invention discloses a Tibetan medicine gnaphalium affine high performance liquid fingerprint spectrum and a method for determining the content of six components. The invention belongs to the technical field of traditional Chinese medicines, an HPLC method is used for establishing 18 batches of gnaphalium affine fingerprint spectrums and generating a characteristic spectrum, and under the condition, the fingerprint spectrums can be obviously distinguished from an adulterant (edelweiss) spectrum; according to the present invention, the HPLC method is adopted to simultaneously determine the main chemical components such as chlorogenic acid, caffeic acid, isochlorogenic acid A, quercetin, luteolin and apigenin in the Tibetan medicine gnaphalium affine, the reliability is verified, and the verification accuracy is improved; the quality control method of the Tibetan medicine gnaphalium affine can be enriched and perfected.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the technical field of traditional Chinese medicines, and specifically refers to a high-performance liquid fingerprint spectrum of Tibetan medicine Herba Gnaphalii and a method for determining the contents of six components. Background Art

[0002] There is a common phenomenon of "one name for multiple medicines" in Tibetan medicine, which makes it difficult to determine the origin and control the quality of Tibetan medicine. The Tibetan medicine Gnaphalium affine D.Don is the dried aerial part of the Asteraceae plant Gnaphalium affine D.Don. It has slender leaves with hair on both sides, a head inflorescence similar to edelweiss, and a yellow involucre. Gnaphalium affine is rich in resources and widely distributed in Tibetan areas. It can be used to treat "Bacon's disease", tumors, gout and rheumatoid arthritis. Its Tibetan transliteration names include "Ganha Baza", "Gande Bazha", "Ganda Baza", etc. It is recorded in many monographs, such as "Jingzhu Materia Medica", "Tibetan Medicine Records", and "Chinese Tibetan Medicine". It is a commonly used medicinal material in Tibetan areas.

[0003] The Tibetan Medicine Records states that the original plants of the medicinal material "Gande Ba Zha" include not only Gnaphalium sibiricum, but also Milky White Fragrant Green, Bell-bell Fragrant Green and Nepal Fragrant Green. The Chinese Tibetan Medicine divides "Gandabaza" into two types: yellow and white. The yellow one is based on Gnaphalium sibiricum, while the white one is based on Milky White Fragrant Green and Two-color Fragrant Green. In addition to the Tibetan areas, Gnaphalium sibiricum is also included in the local standards of other regions in China and used as "Gnaphalium sibiricum". Compared with Gnaphalium sibiricum in other regions, although the plant origin is the same, the chemical composition content and functional indications of the medicinal material are different due to the difference in growth environment. In addition, although Gnaphalium sibiricum is included in the Tibetan Autonomous Region Tibetan Medicinal Material Standard (2012 Edition) as "Gande Ba Zha", the quality control methods of Gnaphalium sibiricum in the standard are only three types: properties, microscopy and thin layer, which are relatively simple and not conducive to the further development and utilization of Gnaphalium sibiricum and quality control.

[0004] In addition, Gnaphalium affine D.Do and Leontopodiumleontopodioides (Willd.) Beauverd are both perennial herbs of the Asteraceae family. The two plants have similar morphology. The Tibetan medicine book "Blue Glaze" describes Gnaphalium affine (Ganda Baza) as "Ganda Baza stems are slender, like Leontopodium leontopodioides...", and "Ganlu Materia Medica Mirror" records that Gnaphalium affine (Gan De Ba Zha) "... leaves and stems are covered with white soft hairs, like Leontopodium leontopodioides; flowers are yellow or white like Leontopodium leontopodioides, with head-shaped inflorescences...". The Tibetan transliteration of Gnaphalium affine is "Ganda Baza" or "Gan De Ba Zha", and the Tibetan transliteration of Leontopodium leontopodioides is "Zabato". They are two different medicines with obvious differences in efficacy. Both are used as medicines with the above-ground parts or the whole plant. After drying, the properties are more similar, which makes it difficult to identify the medicinal materials. Therefore, establishing and improving the quality evaluation method of Tibetan medicine Gnaphalium wilfordii is of great significance for identifying Gnaphalium wilfordii and its adulterants and ensuring the stable quality of Gnaphalium wilfordii medicinal materials.

[0005] There is no research report on the fingerprint of Tibetan medicine Herba Glechomae. The fingerprint reflects the types and quantities of the chemical components of the medicinal material in a comprehensive manner, and can also compare and analyze different batches, which is of great significance for describing and evaluating the quality of the medicinal material. The existing quality control methods of Herba Glechomae cannot well reflect the quality of the medicinal material. Therefore, the use of HPLC to establish the fingerprint of Herba Glechomae and detect the content of its multiple components is of great significance for evaluating the quality of Herba Glechomae, improving the quality control methods of Herba Glechomae, and scientifically developing and utilizing Herba Glechomae resources. Summary of the invention

[0006] The purpose of the present invention is to provide a high-performance liquid fingerprint spectrum of Tibetan medicine Artemisia selengensis and a method for determining the contents of 6 components. The present invention uses an HPLC method to establish fingerprint spectra of 18 batches of Artemisia selengensis and generates a characteristic spectrum, which can be clearly distinguished from the spectrum of a confused product (Edelweiss) under this condition; the present invention uses an HPLC method to establish and simultaneously determine the main chemical components in Tibetan medicine Artemisia selengensis, which are chlorogenic acid, caffeic acid, isochlorogenic acid A, quercetin, luteolin and apigenin, and verifies its reliability. The present invention improves the accuracy and comprehensiveness of medicinal material identification by establishing 6 chemical component models for evaluation; the present invention can enrich and improve the quality control method of Tibetan medicine Artemisia selengensis.

[0007] In order to achieve the above object, the technical solution adopted by the present invention is as follows: a high-performance liquid fingerprint spectrum of Tibetan medicine Herba Gnaphalii and a method for determining the contents of 6 components, the method comprising the following steps:

[0008] (1) Preparation of the test solution: Take about 0.5 g of the test sample, weigh it accurately, place it in a stoppered conical flask, add 25 mL of methanol, weigh it, cool it after ultrasonic treatment, make up the lost weight, filter it with a microporous filter membrane, and take the filtrate to obtain the test solution;

[0009] (2) Preparation of reference solution: Accurately weigh appropriate amounts of chlorogenic acid, caffeic acid, isochlorogenic acid A, quercetin, luteolin and apigenin reference substances, and add organic solvent to prepare a mixed reference solution containing 788 μg / mL chlorogenic acid, 172 μg / mL caffeic acid, 820 μg / mL isochlorogenic acid A, 178 μg / mL quercetin, 538 μg / mL luteolin and 452 μg / mL apigenin;

[0010] (3) Determination of the HPLC fingerprint of Gnaphalium affine: The test sample solutions of 18 batches of Gnaphalium affine were measured in sequence to obtain the chromatograms of each batch of Gnaphalium affine. The spectra of the 18 batches of Gnaphalium affine were processed using the "Chinese Herbal Medicine Chromatographic Fingerprint Similarity Evaluation System" to calibrate the common peaks with reference peaks, generate the Gnaphalium affine fingerprint, and establish its control fingerprint.

[0011] Furthermore, the chromatographic conditions are: Welch AQ-C18 chromatographic column (4.6 mm × 250 mm, 5 μm). Mobile phase: methanol (A)-0.1% phosphoric acid aqueous solution (B), gradient elution (0 min, 15% A; 0-30 min, 15%-30% A; 30-60 min, 30%-40% A; 60-90 min, 40%-55% A; 90-100 min, 75% A; 100-105 min, 75% A; 105-107 min, 75%-15% A; 107-120 min, 15% A), flow rate 1.0 mL / min, detection wavelength 320 nm, column temperature 30°C, injection volume 10 μL.

[0012] Furthermore, the power of the ultrasonic treatment in step (1) is 300W.

[0013] Furthermore, the frequency of the ultrasonic treatment in step (1) is 40 kHz.

[0014] Furthermore, the ultrasonication time in step (1) is 30 minutes.

[0015] Furthermore, the pore size of the microporous filter membrane in step (1) is 0.22 μm.

[0016] Furthermore, the organic solvent in step (2) is methanol.

[0017] Furthermore, the reference peak in step (3) is chlorogenic acid.

[0018] The beneficial effects achieved by the present invention using the above structure are as follows: (1) The present invention uses HPLC to establish fingerprints of 18 batches of Gnaphalium sibiricum, and combines principal component analysis and hierarchical cluster analysis to analyze the common peaks of the 18 batches of Gnaphalium sibiricum, showing the differences and commonalities between different batches of Gnaphalium sibiricum; (2) The present invention uses HPLC to establish a method for simultaneously determining the contents of multiple components in Tibetan medicine Gnaphalium sibiricum, and verifies its reliability; (4) The present invention improves the accuracy and comprehensiveness of medicinal material identification by establishing 6 chemical component models for evaluation; (5) The present invention can enrich and improve the quality control method of Tibetan medicine Gnaphalium sibiricum. BRIEF DESCRIPTION OF THE DRAWINGS

[0019] Figure 1 HPLC fingerprint superposition of Gnaphalium sphaerocephalum (A) and reference spectrum (B);

[0020] Figure 2 HPLC chart of Edelweiss and comparison chart of HPLC of Gnaphalium sphaerocephalum;

[0021] Figure 3 Chromatogram of mixed reference standard (A) and sample control (B).

[0022] The accompanying drawings are used to provide further understanding of the present invention and constitute a part of the specification. They are used to explain the present invention together with the embodiments of the present invention and do not constitute a limitation of the present invention. DETAILED DESCRIPTION

[0023] The technical solutions in the embodiments of the present invention will be clearly and completely described below in conjunction with the drawings in the embodiments of the present invention. Obviously, the described embodiments are only part of the embodiments of the present invention, rather than all the embodiments; based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without making creative work are within the scope of protection of the present invention.

[0024] Unless otherwise defined, all professional and scientific terms used herein have the same meanings as those familiar to those skilled in the art. In addition, any methods and materials similar or equivalent to those described herein may be applied to the present invention. The preferred implementation methods and materials described herein are for demonstration purposes only and are not intended to limit the content of this application.

[0025] The experimental methods in the following examples are conventional methods unless otherwise specified; the experimental materials and test strains used in the following examples are purchased from commercial channels unless otherwise specified.

[0026] Example 1

[0027] Preparation of test solution

[0028] Take about 0.5 g of the test sample, weigh it accurately, put it in a stoppered conical flask, add 25 mL of methanol, weigh the mass, treat it ultrasonically (power 300 W, frequency 40 kHz) for 30 min, cool it, make up for the lost weight, filter it with a 0.22 μm microporous filter membrane, and take the filtrate to obtain the test sample solution.

[0029] Example 2

[0030] Preparation of reference solution

[0031] Accurately weigh appropriate amounts of chlorogenic acid, caffeic acid, isochlorogenic acid A, quercetin, luteolin and apigenin reference substances, and add methanol to prepare a mixed reference solution containing 788 μg / mL of chlorogenic acid, 172 μg / mL of caffeic acid, 820 μg / mL of isochlorogenic acid A, 178 μg / mL of quercetin, 538 μg / mL of luteolin and 452 μg / mL of apigenin.

[0032] Example 3

[0033] Establishment of HPLC fingerprint of Gnaphalium sphaerocephalum

[0034] The test solutions of 18 batches of Gnaphalium sibiricum were measured in sequence to obtain the chromatograms of each batch of Gnaphalium sibiricum. The spectra of 18 batches of Gnaphalium sibiricum were processed using the "Chinese Herbal Medicine Chromatographic Fingerprint Similarity Evaluation System", and chlorogenic acid (peak 6) was used as the reference peak to calibrate the common peaks and generate the Gnaphalium sibiricum fingerprint ( Figure 1 A), and establish its reference fingerprint ( Figure 1 B). The similarities between the fingerprints of each batch of samples and the control were 0.987, 0.976, 0.994, 0.990, 0.991, 0.960, 0.990, 0.975, 0.994, 0.996, 0.993, 0.992, 0.982, 0.995, 0.990, 0.994, 0.992, 0.994, all > 0.900, indicating that the control fingerprint can better reflect the quality of Gnaphalium serrata.

[0035] According to the fingerprint matching results of 18 batches of Gnaphalium wilfordii, a total of 34 common peaks were detected. Compared with the reference substances, 6 known chromatographic peaks were calibrated, namely No. 6 (chlorogenic acid), No. 7 (caffeic acid), No. 13 (isochlorogenic acid A), No. 22 (quercetin), No. 24 (luteolin) and No. 29 (apigenin).

[0036] Example 4

[0037] Comparison of HPLC spectra of Edelweiss and Glehnia littoralis

[0038] According to the method established in the present invention, the test solution of Leontopodium leontopodium was prepared and tested according to the established fingerprint spectrum conditions of Gnaphalium sibiricum. By comparing with the control spectrum of Gnaphalium sibiricum, it was found that there were obvious differences between the two. The results are shown in Figure 2 The results showed that compared with the control spectrum of Glehnia littoralis, the HPLC spectrum of Leontopodium salsa lacked peaks 10, 11, 12, 14, 20, 22, 28, 30, 31, 32, 33, and 34, a total of 12 characteristic peaks, and there were obvious differences. This shows that the HPLC fingerprint spectrum method of Glehnia littoralis established by the present invention can effectively distinguish Glehnia littoralis from its easily confused product (Leontopodium salsa), which is helpful for the authenticity identification of Glehnia littoralis materials.

[0039] Experimental Example 1

[0040] Determination of the contents of the main chemical components in Gnaphalium sphaerocephalum

[0041] The content of active ingredients or index components is one of the most important quality indicators of Tibetan medicine. With the popularization of high performance liquid chromatography in drug testing institutions at all levels and scientific research institutes, the content determination based on index chemical components has become a conventional method for quality control of Tibetan medicine. According to the determination method of Examples 1 to 3 provided by the present invention, the content of the main chemical components in Gnaphalium sibiricum is determined, and the obtained spectrum is as follows: Figure 3 Shown: 1-chlorogenic acid, 2-caffeic acid, 3-isochlorogenic acid A, 4-quercetin, 5-luteolin, 6-apigenin.

[0042] Result analysis: Figure 3 As shown in the figure, the main chemical components of Gnaphalium wilfordii are chlorogenic acid, caffeic acid, isochlorogenic acid A, quercetin, luteolin and apigenin.

[0043] Experimental Example 2

[0044] Linear relationship investigation

[0045] Take the reference solution, dilute it with methanol to a series of mass concentrations, filter it, and inject it for determination under chromatographic conditions. The determination results are used to make a standard curve with mass concentration as the horizontal axis (x) and peak area as the vertical axis (y), and calculate the regression equation of each component.

[0046] Table 1 Regression equations of the main components of Gnaphalium sphaerocephalum

[0047] Compound Name Regression equation r Linear range (μg / mL) Chlorogenic acid y = 10 536x - 27 432 1 1.54~788 Caffeic acid y=18 244x-13 208 0.999 9 0.34~172 Isochlorogenic acid A y=11 399x-47 195 1 1.60~820 Quercetin y=38 285x-25 249 0.999 9 0.35~178 Luteolin y = 33 962x - 19 796 0.999 9 1.05~538 Apigenin y=27 864x-16 048 0.999 9 0.88~451

[0048] Result analysis: As shown in Table 1, the six compounds have good linear relationships within their respective ranges.

[0049] Experimental Example 3

[0050] Precision test

[0051] Take the reference solution, inject it continuously for 6 times under chromatographic conditions, and measure the RSD value of the peak area of ​​each component.

[0052] Result analysis: as shown in Table 2. The RSD values ​​of each component were less than 1%, indicating that the instrument had good precision.

[0053] Table 2 Results of precision test of each component of Gnaphalium serrata

[0054] Compound Name RSD(%) Chlorogenic acid 0.16 Caffeic acid 0.83 Isochlorogenic acid A 0.70 Quercetin 0.55 Luteolin 0.31 Apigenin 0.20

[0055] Experimental Example 4

[0056] Analysis of repeatability experimental results: As shown in Table 3, the results are in line with the pharmacopoeia standards, indicating that the method has good repeatability.

[0057] Table 3 Repeatability test results of each component of Gnaphalium sphaerocephalum

[0058] Compound Name RSD(%) Chlorogenic acid 2.88 Caffeic acid 2.84 Isochlorogenic acid A 2.89 Quercetin 3.88 Luteolin 3.50 Apigenin 3.44

[0059] Table 4 Stability test results of each component of Gnaphalium serrata

[0060] Compound Name RSD(%) Chlorogenic acid 0.30 Caffeic acid 1.66 Isochlorogenic acid A 0.86 Quercetin 1.02 Luteolin 0.61 Apigenin 0.71

[0061] Accurately weigh 6 portions of the test sample (GA-14), prepare the test sample solution according to the method provided by the present invention, inject and measure under chromatographic conditions, and measure the repeatability RSD values ​​of the 6 components.

[0062] Experimental Example 5

[0063] Stability test

[0064] One portion of the test sample (GA-14) was accurately weighed, and a test solution was prepared according to the method provided by the present invention. The sample was injected and measured under chromatographic conditions at 0, 2, 4, 8, 12 and 24 h, respectively, the content of each component was measured, and the RSD value of the stability was calculated. The results are shown in Table 4.

[0065] Result analysis: As shown in Table 4, the RSD values ​​of each component were less than 2%, indicating that the test solution had good stability within 24 hours.

[0066] Experimental Example 6

[0067] Sample recovery test

[0068] Accurately weigh 6 portions of 0.25 g of a medicinal material (GA-14) with a known content, add an appropriate amount of a reference substance, prepare a test solution according to the method provided by the present invention, perform injection measurement under chromatographic conditions, and calculate the recovery rate.

[0069] Result analysis: as shown in Table 5. The average recovery rate of each component meets the pharmacopoeia standard.

[0070] Table 5 Sample recovery test

[0071]

[0072]

[0073] Experimental Example 7

[0074] Sample content detection: 18 batches of test solutions of Gnaphalium wilfordii were prepared according to the method provided by the present invention, and the samples were injected and measured under chromatographic conditions to calculate the content of each component. The results are shown in Table 6.

[0075] Result analysis: The contents of chlorogenic acid and apigenin in GA-6 were significantly lower than those in the other batches, and the contents of isochlorogenic acid A and luteolin were also low; the caffeic acid content in GA-8 was higher and the quercetin content was significantly lower, which was consistent with the results of the above fingerprint analysis, indicating that the contents of these six components in GA-6 and GA-8 were different from those in the other batches, but it was not clear whether these six components were the representative factors that distinguished GA-6 and GA-8 from the other batches.

[0076] Table 6 Results of determination of the content of each component

[0077]

[0078] Although embodiments of the present invention have been shown and described, it will be appreciated by those skilled in the art that various changes, modifications, substitutions and variations may be made to the embodiments without departing from the principles and spirit of the present invention, and that the scope of the present invention is defined by the appended claims and their equivalents.

[0079] The present invention and its embodiments are described above, and such description is not restrictive. The drawings show only one embodiment of the present invention, and the actual structure is not limited thereto. In short, if ordinary technicians in the field are inspired by it, without departing from the purpose of the invention, they can design a structure and embodiment similar to the technical solution without creativity, which should belong to the protection scope of the present invention.

Claims

1. A high performance liquid fingerprint spectrum of Tibetan medicine Herba Gnaphalii and a method for determining the contents of six components, characterized in that: The determination method comprises the following steps: (1) Preparation of the test solution: Take the test sample, weigh it accurately, place it in a stoppered conical flask, add methanol, weigh it, cool it after ultrasonic treatment, make up the lost weight, filter it with a microporous membrane, and take the filtrate to obtain the test solution; (2) Preparation of reference solution: Accurately weigh appropriate amounts of chlorogenic acid, caffeic acid, isochlorogenic acid A, quercetin, luteolin and apigenin reference substances, and add organic solvent to prepare a mixed reference solution containing chlorogenic acid, caffeic acid, isochlorogenic acid A, quercetin, luteolin and apigenin; (3) Determination of HPLC fingerprint of Gnaphalium affine: 18 batches of Gnaphalium affine were tested in turn to obtain the chromatograms of each batch of Gnaphalium affine. The spectra of the 18 batches of Gnaphalium affine were processed using the "Chinese Herbal Medicine Chromatographic Fingerprint Similarity Evaluation System" to calibrate the common peaks with reference peaks, generate Gnaphalium affine fingerprints, and establish their control fingerprints.

2. The high-performance liquid fingerprint of Tibetan medicine Herba Gnaphalii and the method for determining the contents of six components according to claim 1, characterized in that: In step (1), the sample is about 0.5 g and the methanol is 25 mL.

3. The high-performance liquid fingerprint of Tibetan medicine Herba Gnaphalii and the method for determining the contents of six components according to claim 2, characterized in that: The contents in step (2) are: 788 μg / mL of chlorogenic acid, 172 μg / mL of caffeic acid, 820 μg / mL of isochlorogenic acid A, 178 μg / mL of quercetin, 538 μg / mL of luteolin and 452 μg / mL of apigenin.

4. The high-performance liquid fingerprint of Tibetan medicine Herba Gnaphalii and the method for determining the contents of six components according to claim 3, characterized in that: The chromatographic conditions are: Welch AQ-C18 chromatographic column (4.6 mm × 250 mm, 5 μm); mobile phase: methanol (A)-0.1% phosphoric acid aqueous solution (B), gradient elution (0 min, 15% A; 0-30 min, 15%-30% A; 30-60 min, 30%-40% A; 60-90 min, 40%-55% A; 90-100 min, 75% A; 100-105 min, 75% A; 105-107 min, 75%-15% A; 107-120 min, 15% A), flow rate 1.0 mL / min, detection wavelength 320 nm, column temperature 30°C, injection volume 10 μL.

5. The high-performance liquid fingerprint of Tibetan medicine Herba Gnaphalii and the method for determining the contents of six components according to claim 4, characterized in that: The power of the ultrasonic treatment in step (1) is 300W.

6. The high-performance liquid fingerprint spectrum of Tibetan medicine Herba Gnaphalii and the method for determining the contents of six components according to claim 5, characterized in that: The frequency of the ultrasonic treatment in step (1) is 40 kHz.

7. The high-performance liquid fingerprint spectrum of Tibetan medicine Herba Gnaphalii and the method for determining the contents of six components according to claim 6, characterized in that: The ultrasonication time in step (1) is 30 min.

8. The high-performance liquid fingerprint spectrum of Tibetan medicine Herba Gnaphalii and the method for determining the contents of six components according to claim 7, characterized in that: The pore size of the microporous filter membrane in step (1) is 0.22 μm.

9. The high-performance liquid fingerprint spectrum of Tibetan medicine Herba Gnaphalii and the method for determining the contents of six components according to claim 8, characterized in that: The organic solvent in step (2) is methanol.

10. The high performance liquid fingerprint spectrum of Tibetan medicine Herba Gnaphalii and the method for determining the contents of six components according to claim 9, characterized in that: The reference peak in step (3) is chlorogenic acid.